223 related articles for article (PubMed ID: 31529284)
1. ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles.
Dos Santos Rodrigues B; Kanekiyo T; Singh J
Pharm Res; 2019 Sep; 36(11):161. PubMed ID: 31529284
[TBL] [Abstract][Full Text] [Related]
2. Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease.
Arora S; Layek B; Singh J
Mol Pharm; 2021 Feb; 18(2):714-725. PubMed ID: 32787268
[TBL] [Abstract][Full Text] [Related]
3. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
[TBL] [Abstract][Full Text] [Related]
4. Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain.
Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
J Pharmacol Exp Ther; 2020 Sep; 374(3):354-365. PubMed ID: 32561686
[TBL] [Abstract][Full Text] [Related]
5. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.
Rodrigues BDS; Kanekiyo T; Singh J
Mol Pharm; 2020 Jun; 17(6):2054-2063. PubMed ID: 32315185
[TBL] [Abstract][Full Text] [Related]
6. Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection.
Dos Santos Rodrigues B; Oue H; Banerjee A; Kanekiyo T; Singh J
J Control Release; 2018 Sep; 286():264-278. PubMed ID: 30071253
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characterization of CPP and transferrin modified liposomes encapsulating pDNA.
Dos Santos Rodrigues B; Kanekiyo T; Singh J
Nanomedicine; 2020 Aug; 28():102225. PubMed ID: 32485318
[TBL] [Abstract][Full Text] [Related]
8. Efficient neuronal targeting and transfection using RVG and transferrin-conjugated liposomes.
Dos Santos Rodrigues B; Arora S; Kanekiyo T; Singh J
Brain Res; 2020 May; 1734():146738. PubMed ID: 32081534
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
10. Grafting of cell-penetrating peptide to receptor-targeted liposomes improves their transfection efficiency and transport across blood-brain barrier model.
Sharma G; Modgil A; Sun C; Singh J
J Pharm Sci; 2012 Jul; 101(7):2468-78. PubMed ID: 22517732
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.
Kong L; Li XT; Ni YN; Xiao HH; Yao YJ; Wang YY; Ju RJ; Li HY; Liu JJ; Fu M; Wu YT; Yang JX; Cheng L
Int J Nanomedicine; 2020; 15():2841-2858. PubMed ID: 32425521
[TBL] [Abstract][Full Text] [Related]
12. Functionalized liposomal nanoparticles for efficient gene delivery system to neuronal cell transfection.
Dos Santos Rodrigues B; Banerjee A; Kanekiyo T; Singh J
Int J Pharm; 2019 Jul; 566():717-730. PubMed ID: 31202901
[TBL] [Abstract][Full Text] [Related]
13. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.
Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J
J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036
[TBL] [Abstract][Full Text] [Related]
14. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
15. GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier.
Arora S; Sharma D; Singh J
ACS Chem Neurosci; 2020 Jun; 11(11):1620-1633. PubMed ID: 32352752
[TBL] [Abstract][Full Text] [Related]
16. Transferrin-modified liposome promotes α-mangostin to penetrate the blood-brain barrier.
Chen ZL; Huang M; Wang XR; Fu J; Han M; Shen YQ; Xia Z; Gao JQ
Nanomedicine; 2016 Feb; 12(2):421-30. PubMed ID: 26711963
[TBL] [Abstract][Full Text] [Related]
17. Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma.
Wang X; Zhao Y; Dong S; Lee RJ; Yang D; Zhang H; Teng L
Molecules; 2019 Sep; 24(19):. PubMed ID: 31574945
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy.
Arora S; Singh J
Int J Pharm; 2021 Oct; 608():121095. PubMed ID: 34543617
[TBL] [Abstract][Full Text] [Related]
19. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo.
Johnsen KB; Bak M; Melander F; Thomsen MS; Burkhart A; Kempen PJ; Andresen TL; Moos T
J Control Release; 2019 Feb; 295():237-249. PubMed ID: 30633947
[TBL] [Abstract][Full Text] [Related]
20. Transferrin-functionalized liposomes loaded with vitamin VB12 for Alzheimer's disease therapy.
Andrade S; Ramalho MJ; Loureiro JA; Pereira MC
Int J Pharm; 2022 Oct; 626():122167. PubMed ID: 36075524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]